134 related articles for article (PubMed ID: 11730704)
1. Intra-prefrontal cortex injections of SCH 23390 influence nucleus accumbens dopamine levels 24 h post-infusion.
Olsen CM; Duvauchelle CL
Brain Res; 2001 Dec; 922(1):80-6. PubMed ID: 11730704
[TBL] [Abstract][Full Text] [Related]
2. SKF 83959 is an antagonist of dopamine D1-like receptors in the prefrontal cortex and nucleus accumbens: a key to its antiparkinsonian effect in animals?
Cools AR; Lubbers L; van Oosten RV; Andringa G
Neuropharmacology; 2002 Feb; 42(2):237-45. PubMed ID: 11804620
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D1 receptor-dependent regulation of extracellular citrulline level in the rat nucleus accumbens during conditioned fear response.
Saulskaya NB; Fofonova NV; Sudorghina PV; Saveliev SA
Neurosci Lett; 2008 Aug; 440(2):185-9. PubMed ID: 18555608
[TBL] [Abstract][Full Text] [Related]
4. Sustained extracellular signal-regulated kinase 1/2 phosphorylation in neonate 6-hydroxydopamine-lesioned rats after repeated D1-dopamine receptor agonist administration: implications for NMDA receptor involvement.
Papadeas ST; Blake BL; Knapp DJ; Breese GR
J Neurosci; 2004 Jun; 24(26):5863-76. PubMed ID: 15229233
[TBL] [Abstract][Full Text] [Related]
5. Medial prefrontal cortical D1 receptor modulation of the meso-accumbens dopamine response to stress: an electrochemical study in freely-behaving rats.
Doherty MD; Gratton A
Brain Res; 1996 Apr; 715(1-2):86-97. PubMed ID: 8739626
[TBL] [Abstract][Full Text] [Related]
6. Prefrontal, accumbal [shell] and ventral striatal mechanisms in jaw movements and non-cyclase-coupled dopamine D1-like receptors.
Adachi K; Hasegawa M; Fujita S; Lee J; Cools AR; Waddington JL; Koshikawa N
Eur J Pharmacol; 2003 Jul; 473(1):47-54. PubMed ID: 12877937
[TBL] [Abstract][Full Text] [Related]
7. Basolateral amygdala modulation of the nucleus accumbens dopamine response to stress: role of the medial prefrontal cortex.
Stevenson CW; Gratton A
Eur J Neurosci; 2003 Mar; 17(6):1287-95. PubMed ID: 12670317
[TBL] [Abstract][Full Text] [Related]
8. D1-D2 dopamine receptor interaction within the nucleus accumbens mediates long-loop negative feedback to the ventral tegmental area (VTA).
Rahman S; McBride WJ
J Neurochem; 2001 Jun; 77(5):1248-55. PubMed ID: 11389175
[TBL] [Abstract][Full Text] [Related]
9. Prefrontal cortical D1 dopamine receptors modulate subcortical D2 dopamine receptor-mediated stress responsiveness.
Scornaiencki R; Cantrup R; Rushlow WJ; Rajakumar N
Int J Neuropsychopharmacol; 2009 Oct; 12(9):1195-208. PubMed ID: 19275776
[TBL] [Abstract][Full Text] [Related]
10. Effects of repeated cocaine administration on dopamine D1 receptor modulation of mesocorticolimbic GABA and glutamate transmission.
Steketee JD; Liu K
Brain Res; 2018 Nov; 1698():106-113. PubMed ID: 30075100
[TBL] [Abstract][Full Text] [Related]
11. Decreased mesolimbic dopaminergic signaling underlies the waning of maternal caregiving across the postpartum period in rats.
Grieb ZA; Vitale EM; Morrell JI; Lonstein JS; Pereira M
Psychopharmacology (Berl); 2020 Apr; 237(4):1107-1119. PubMed ID: 31927604
[TBL] [Abstract][Full Text] [Related]
12. Consolidation of object recognition memory requires simultaneous activation of dopamine D1/D5 receptors in the amygdala and medial prefrontal cortex but not in the hippocampus.
Rossato JI; Radiske A; Kohler CA; Gonzalez C; Bevilaqua LR; Medina JH; Cammarota M
Neurobiol Learn Mem; 2013 Nov; 106():66-70. PubMed ID: 23891712
[TBL] [Abstract][Full Text] [Related]
13. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
14. Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade.
Ramos M; Goñi-Allo B; Aguirre N
Neuropsychopharmacology; 2005 Dec; 30(12):2180-91. PubMed ID: 15841107
[TBL] [Abstract][Full Text] [Related]
15. Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex.
Granon S; Passetti F; Thomas KL; Dalley JW; Everitt BJ; Robbins TW
J Neurosci; 2000 Feb; 20(3):1208-15. PubMed ID: 10648725
[TBL] [Abstract][Full Text] [Related]
16. Stress-induced activation of ventral tegmental mu-opioid receptors reduces accumbens dopamine tone by enhancing dopamine transmission in the medial pre-frontal cortex.
Latagliata EC; Valzania A; Pascucci T; Campus P; Cabib S; Puglisi-Allegra S
Psychopharmacology (Berl); 2014 Oct; 231(21):4099-108. PubMed ID: 24958228
[TBL] [Abstract][Full Text] [Related]
17. Stimulating dopamine D1 receptors increases the locomotor activity of developing rats.
Shieh GJ; Walters DE
Eur J Pharmacol; 1996 Sep; 311(2-3):103-7. PubMed ID: 8891588
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic modulation of nitric oxide synthase activity in subregions of the rat nucleus accumbens.
Hoque KE; West AR
Synapse; 2012 Mar; 66(3):220-31. PubMed ID: 22034069
[TBL] [Abstract][Full Text] [Related]
19. Injection of SCH 23390 into the ventral tegmental area blocks the development of neurochemical but not behavioral sensitization to cocaine.
Steketee JD
Behav Pharmacol; 1998 Feb; 9(1):69-76. PubMed ID: 9832950
[TBL] [Abstract][Full Text] [Related]
20. Prefrontal cortex D1 modulation of the reinforcing properties of cocaine.
Olsen CM; Duvauchelle CL
Brain Res; 2006 Feb; 1075(1):229-35. PubMed ID: 16460710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
